Popular Pre-Market Trades in US Stocks
Stocks with the Largest Pre-Market Gains in US Stocks
PepGen is up 87.97% in pre-market trading. According to recent key news:
<ol>
<li>
On September 24, PepGen announced the pricing of a $100 million public offering, leading to a significant increase in its stock price. The offering is priced at $3.20 per share, with a total of 31,250,000 shares issued, expected to raise a total of $100 million.
</li>
<li>
On September 24, PepGen released positive data from its FREEDOM-DM1 Phase 1 clinical trial, showing an average splice correction rate of 53.7% after a single dose of 15 mg/kg of PGN-EDODM1, significantly higher than the previously reported splice correction rate in DM1 patients.
</li>
<li>
On September 24, Guggenheim reiterated its buy rating on PepGen and maintained its target price of $6, further driving up the stock price. The biotechnology sector has shown strong performance recently, with noticeable inflows of capital
</li>
</ol>

HXHX

ABVE

Haoxin pre-market up 9.09%; Above Food Ingredients pre-market up 7.98%; PepGen pre-market up 87.97%; WORK Medical Tech pre-market up 57.51%; OFA pre-market up 39.85%

Pre-market hot trades in US stocks: Haoxin up 9.09% in pre-market; Above Food Ingredients up 7.98% in pre-market